Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome

Intensive Care Medicine, Supplement

Volumn 27, Issue 1, 2001, Pages 1187-1193

  Gando, S ^a   Nishihira, J ^a   Kobayashi, S ^a   Morimoto, Y ^a   Nanzaki, S ^a   Kemmotsu, O ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cortisol; Macrophage migration inhibitory factor (MIF); Multiple organ dysfunction syndrome (MODS); Systemic inflammatory response syndrome (SIRS); Tumor necrosis factor (TNF )

Indexed keywords

GAMMA INTERFERON; HYDROCORTISONE; MACROPHAGE MIGRATION INHIBITION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; INTENSIVE CARE; MALE; MULTIPLE ORGAN FAILURE; PATHOGENESIS; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; FEMALE; HUMANS; HYDROCORTISONE; INTERFERON TYPE II; JAPAN; LEAST-SQUARES ANALYSIS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034904935     PISSN: 09351701     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001340000818     Document Type: Article

References (27)

1. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity
2. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction
3. MIF as a glucocorticoid-induced modulator of cytokine production
4. MIF rediscovered: Cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response
5. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
6. Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system
7. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor
8. Protection from septic shock by neutralization of macrophage migration inhibitory factor
9. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
10. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study
11. Role of tumor necrosis factor-α in disease states and inflammation
12. Anticytokine strategies in the treatment of the systemic inflammatory response syndrome
13. The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious, and inflammatory stress
14. APACHE II: A severity classification system
15. An expanded definition of the adult respiratory distress syndrome
16. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome
17. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide
18. Novel pathophysiological aspects of macrophage migration inhibitory factor
19. Migration inhibitory factor expression in experimentally induced endotoxemia
20. The pathogenesis of sepsis
21. An overview of mortality risk prediction in sepsis
22. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitor factor (MIF)
23. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock
24. Interferon gamma-1b in the treatment of compensatory anti-inflammatory response syndrome
25. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment
26. Corticosteroids in septic shock: Resurrection of the last rites?
27. Sepsis: A new hypothesis for pathogenesis of the disease process